Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 613 publications

Personalized medicine in acromegaly: insights from the ACROFAST clinical trial.

Personalized medicine in acromegaly: insights from the ACROFAST clinical trial.

Journal: Expert review of endocrinology & metabolism
Published: September 29, 2025

Adherence, duration and healthcare costs in a real-world population of patients with acromegaly.

Adherence, duration and healthcare costs in a real-world population of patients with acromegaly.

Journal: Journal of comparative effectiveness research
Published: August 29, 2025

Consensus on acromegaly therapeutic outcomes: an update.

Consensus on acromegaly therapeutic outcomes: an update.

Journal: Nature reviews. Endocrinology
Published: June 30, 2025

Impact of Medical Therapies on Cardiovascular Risk Factors in Acromegaly.

Impact of Medical Therapies on Cardiovascular Risk Factors in Acromegaly.

Journal: Cureus
Published: June 13, 2025

Growth Hormone Signaling in Bladder Cancer: Transcriptomic Profiling of Patient Samples and In Vitro Evidence of Therapy Resistance via ABC Transporters and EMT Activation.

Growth Hormone Signaling in Bladder Cancer: Transcriptomic Profiling of Patient Samples and In Vitro Evidence of Therapy Resistance via ABC Transporters and EMT Activation.

Journal: International journal of molecular sciences
Published: May 27, 2025

Cost-utility analysis of second line acromegaly treatment in France.

Cost-utility analysis of second line acromegaly treatment in France.

Journal: Annales d'endocrinologie
Published: May 26, 2025

Cost-utility analysis of second line acromegaly treatment in France.

Cost-utility analysis of second line acromegaly treatment in France.

Journal: Annales d'endocrinologie
Published: May 26, 2025

Disease-Specific Mortality in Patients With Acromegaly Treated With Pegvisomant: An ACROSTUDY Analysis.

Disease-Specific Mortality in Patients With Acromegaly Treated With Pegvisomant: An ACROSTUDY Analysis.

Journal: Endocrine connections
Published: May 07, 2025

The Combination Therapy of Pasireotide LAR Plus Pegvisomant and Cabergoline Relieved Acromegaly-Related Headache in a Female Patient with AIP-Mutated Acromegaly: A Case Report.

The Combination Therapy of Pasireotide LAR Plus Pegvisomant and Cabergoline Relieved Acromegaly-Related Headache in a Female Patient with AIP-Mutated Acromegaly: A Case Report.

Journal: Endocrine, metabolic & immune disorders drug targets
Published: March 17, 2025

Safe Continuation of Pegvisomant During Pregnancy in a Patient With Fibrous Dysplasia/McCune-Albright Syndrome.

Safe Continuation of Pegvisomant During Pregnancy in a Patient With Fibrous Dysplasia/McCune-Albright Syndrome.

Journal: JCEM case reports
Published: March 17, 2025

Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas.

Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas.

Journal: Endocrine connections
Published: February 20, 2025

Impact of pasireotide on lipid and glucose metabolism in patients with acromegaly: a systematic review and meta-analysis.

Impact of pasireotide on lipid and glucose metabolism in patients with acromegaly: a systematic review and meta-analysis.

Journal: Journal of endocrinological investigation
Published: February 14, 2025
Showing 1-12 of 613

Last Updated: 10/31/2025